Fungal antigens, fungal DNA, and anti-fungal antibodies can be used as non-invasive biomarkers for invasive fungal infections (IFIs). MiraVista Diagnostics (MVD) specializes in developing diagnostic tests to detect these biomarkers. These tests provide a rapid, cost-efficient alternative to invasive testing, often required otherwise to diagnose IFIs. Over the past 20 years MVD tests have revolutionized diagnosis and treatment monitoring of IFIs in animals. Use has been reported in many peer-reviewed publications.
Geographic location of enzootic invasive fungal infections (IFIs) is an important consideration. Cryptococcosis and aspergillosis, along with other invasive molds, occur anywhere in the U.S. Although infections can occur sporadically anywhere, IFIs due to dimorphic fungi (Blastomyces, Histoplasma, and Coccidioides) are found more commonly in predictable locations. The map below provides a rough estimate of enzootic regions.